Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy

Author： Vidal Francesc   Domingo Pere   Viladés Consuelo   Peraire Joaquim   Arnedo Mireia   Alcamí José   Leal Manuel   Villarroya Francesc   Gatell Josep Ma  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.11, 2011-11, pp. : 1365-1382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3379-3389

Bentham Science Publishers

Access to resources Recommend Favorite

Salvage antiretroviral therapy in HIV infection

By Walmsley Sharon L   Loutfy Mona R  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 81-90

Informa Healthcare

Access to resources Recommend Favorite

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults

By Achenbach Chad J   Darin Kristin M   Murphy Robert L   Katlama Christine  

Future Virology, Vol. 6, Iss. 2, 2011-02 ,pp. : 157-177

Future Medicine

Access to resources Recommend Favorite

Lipodystrophy Syndrome in Patients with HIV Infection: Quality of Life Issues

By Martínez E.  

Drug Safety, Vol. 24, Iss. 3, 2001-01 ,pp. : 157-166

Adis International

Access to resources Recommend Favorite

HIV-Therapy Associated Lipodystrophy: Experimental and Clinical Evidence for the Pathogenesis and Treatment

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite